/

Società

So

Non verificato

SonoThera

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaSaluteScienza

11 comunicati stampa

Guarda tutti i comunicati

10/06/2026

Scienza

Attrezzature medico-sanitarie

Sanità

Biotecnologia

Medicina - Varie

Biologia

Farmaceutica

Salute

SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines

Fonte

Emittente

1.00

0

05/05/2026

Eventi

Igiene alimentare

Salute

Biotecnologia

Medicina - Varie

Farmaceutica

SonoThera to Present Non-Viral RIPPLE™ Platform Data Demonstrating Multi-Tissue Delivery and Gene Expression at ASGCT 2026

Fonte

Emittente

1.00

0

05/03/2026

Eventi

Finanza

Industria

Salute

Biotecnologia

Sanità

Scienza

SonoThera Presents New Preclinical Data at MDA 2026 Highlighting RIPPLE™ as an Efficient, Scalable, Nonviral Platform for Full-Length Dystrophin Delivery in DMD

Fonte

Emittente

1.00

0

08/01/2026

Eventi

Scienza

Finanza

Biotecnologia

Medicina - Varie

Associazioni/Professionisti

Farmaceutica

Salute

SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies

Fonte

Emittente

1.00

0

08/12/2025

Industria

Scienza

Biotecnologia

Farmaceutica

Salute

Medicina - Varie

Sanità

SonoThera Presents New Data at ASH 2025 Demonstrating Durable Factor VIII Expression Using Ultrasound Mediated Gene Delivery in Treating Hemophilia A

Fonte

Emittente

1.00

0

05/11/2025

Eventi

Industria

Scienza

Biotecnologia

Farmaceutica

Salute

Medicina - Varie

SonoThera Presents New Data at ASN Kidney Week 2025 Demonstrating Full-Length Col4a5 Gene Expression Using Ultrasound Mediated Gene Delivery in Treating X-Linked Alport Syndrome

Fonte

Emittente

1.00

0

07/10/2025

Scienza

Attrezzature medico-sanitarie

Biotecnologia

Medicina - Varie

Sanità

Salute

Eventi

SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy

Fonte

Emittente

1.00

0

06/05/2025

Eventi

Fiere

Industria

Salute

Biotecnologia

Medicina nucleare

Scienza

SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A

Fonte

Emittente

1.00

0

10/03/2025

Eventi

Salute

Biotecnologia

Sanità

Scienza

Farmaceutica

SonoThera Presents New Data at the 2025 MDA Conference Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery (UMD) in Treating Duchenne Muscular Dystrophy

Fonte

Emittente

1.00

0

11/11/2024

Eventi

Scienza

Biotecnologia

Cardiologia

Sanità

Salute

Farmaceutica

SonoThera to Present Preclinical Data on Ultrasound-Mediated Gene Delivery Platform to the Heart at the American Heart Association (AHA) Scientific Sessions 2024

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0